missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Carbidopa Pharmaceutical Secondary Standard, MilliporeSigma™ Supelco™
Supplier: Merck Emd Millipore PHR16551G
Description
Carbidopa is a peripheral decarboxylase inhibitor which is often formulated with levodopa for the management of the symptoms of Parkinsonâ²s disease. Its mode of action involves the reduction of systemic production of dopamine and minimization of undesirable effects such as nausea.Pharmaceutical secondary standard for application in quality control. Provides pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards. Featured Industries: Pharmaceutical (small molecule)Specifications
| 38821-49-7 | |
| C10H14N2O4 · H2O | |
| (S)-3-(3,4-Dihydroxyphenyl)-2-hydrazino-2-methylpropionic acid monohydrate | |
| 1 g | |
| Certified Reference Material |
| These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available. | |
| MFCD00889211 | |
| Certified Reference Material | |
| 244.24 |